New medicines that spur weight loss and address diabetes have been getting the general public—as well as the pharmaceutical marketplace—by storm. The latest entrant, Zepbound, recently joined Ozempic, Wegovy, Victoza and Many others inside of a growing class of medicine termed GLP-1 receptor agonists.enhanced heart rate. Saxenda® can enhance y